⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.
Mitochondrial Dysfunction
Current understanding
Energy failure as an aging driver; target of exercise, NAD+, and urolithin A narratives.
Evidence log
- 2026-11-13 — The mitophagy-ferroptosis nexus in cardiac aging: A proposed exercise-responsive framework.: [expert-opinion] Review synthesis, no new primary data: extends exercise–mitochondrial-quality-control framing to a proposed mitophagy–iron-handling–lipid-peroxidation nexus in cardiac aging, without demonstrating that this pathway mediates exercise benefits in humans. [expert-opinion] (novelty: 3)
- 2026-11-13 — Cellular senescence and the hallmarks of ageing: Evaluating evidence for a causal mechanistic role.: [expert-opinion] Review, no new primary data: evaluates mitochondrial dysfunction and cellular senescence as reciprocally connected aging mechanisms rather than a uniformly one-way causal sequence, without establishing which direction dominates in human tissues or demonstrating human benefit from combined targeting. [expert-opinion] (novelty: 3)
- 2026-11-14 — Identification of mitophagy inducers for Alzheimer’s disease via high-throughput endogenous ATP5B tagging system.: [animal-model] Endogenous ATP5B-tagging screen followed by an Alzheimer’s mouse-model study reports flupentixol-induced mitophagy through mitochondrial AMPK recruitment and activation alongside improved cognitive and pathological outcomes, adding a pharmacological mitochondrial-quality-control route without establishing human efficacy or slowed organismal aging. [animal-model] (novelty: 3)
- 2026-11-11 — The Short Peptide Elamipretide Delays Ovarian Aging in Mice: News report of mouse experiments [animal-model] and human oocyte culture experiments [mechanism-plausible] describes improved oocyte quality with mitochondria-targeted elamipretide (SS-31), apparently overlapping the already-logged reproductive-aging study while adding a reported human in vitro readout, not evidence of improved fertility or delayed menopause in humans. [animal-model] (novelty: 3)
- 2026-11-10 — Urolithin A plus EGCG enhances mitophagy associated pathways, mitochondrial dynamics, and bioenergetic function in humanized amyloid-β knock-in mice.: [animal-model] Humanized amyloid-β knock-in mouse study reports that combined urolithin A and EGCG improves mitochondrial bioenergetic function and promotes fusion and biogenesis alongside reduced amyloid pathology and improved cognition, extending combination-treatment evidence without establishing which mitochondrial changes mediate the behavioral effects or whether benefits translate to humans. [animal-model] (novelty: 3)
- 2026-10-20 — Proteostasis stress alters mitochondrial levels and localization of SOD2 during cellular senescence.: [mechanism-plausible] Preclinical cellular study identifies impaired mitochondrial localization and aggregation of SOD2 under proteostasis stress as a route to mitochondrial oxidative imbalance, extending existing mitochondrial-protein-insolubility findings to a specific antioxidant enzyme without demonstrating organismal lifespan effects or human intervention efficacy. [mechanism-plausible] (novelty: 3)
- 2026-11-11 — Engineering ATP import in yeast uncovers a synthetic route to extend cellular lifespan.: Yeast replicative-lifespan study [animal-model] reports that synthetic nucleotide-transporter-mediated ATP import or extracellular ATP exposure extends replicative lifespan and shifts cells away from mitochondrial dysfunction-associated aging states, supporting a causal role for ATP availability in this model without establishing mitochondrial repair, mammalian lifespan extension, or human benefit from ATP supplementation. [animal-model] (novelty: 4)
- 2026-11-13 — Neuropeptide signaling regulates mitochondrial UPR activity and extended lifespan resulting from methionine restriction.: C. elegans lifespan study [animal-model] identifies PKC-1-dependent dense-core vesicle neuropeptide signaling involving INS-27, INS-34, and INS-35 as a route coupling intestinal methionine restriction to selective mitochondrial unfolded protein response activation, altered mitochondrial dynamics, and lifespan extension, without establishing conservation or intervention benefit in humans. [animal-model] (novelty: 3)
- 2026-08-29 — Peripheral blood mitochondrial DNA copy number is associated with cardiac diastolic dysfunction in frail older adults.: Human observational study [human-observational] reports an independently adjusted association between lower peripheral blood mtDNA copy number and cardiac diastolic dysfunction in older adults, strongest in frail individuals, without establishing that blood mtDNA copy number measures myocardial mitochondrial function or that increasing it improves cardiac outcomes. [human-observational] (novelty: 3)
- 2026-10-07 — Lysine degradation-related metabolic remodeling in sarcopenia: Mendelian randomization prioritization and multi-omics-based characterization.: Human metabolome-wide Mendelian randomization integrated with muscle and serum multi-omics [human-observational] prioritizes lysine degradation and impaired trimethyllysine-derived carnitine biosynthesis as candidate contributors to reduced appendicular lean mass, adding a potential metabolic input to muscle mitochondrial dysfunction while leaving causality dependent on genetic-instrument assumptions and establishing neither direct mitochondrial functional impairment nor supplementation benefit. [human-observational] (novelty: 3)
- 2026-10-15 — Proteomic and β-hydroxybutyrylation Landscapes Reveal AMPKα2-Associated Modulation in HUCMSC-Derived Exosome-Mediated Amelioration of Cardiac Aging.: Mouse cardiac-aging study [animal-model] reports that human umbilical cord MSC-derived exosomes improved age-associated cardiac dysfunction alongside proteomic and lysine β-hydroxybutyrylation remodeling linked to AMPKα2, adding a post-translational metabolic-regulation route without establishing mitochondrial respiratory rescue or human benefit from the supplied evidence. [animal-model] (novelty: 3)
- 2026-03-31 — Reprogramming the mitochondrial-circadian energy code with incretins.: Review synthesis [expert-opinion], with no new primary data reported, extends existing GLP-1–mitochondria framing to a proposed shared mitochondrial–circadian disruption in obesity and aging, hypothesizing restoration by GLP-1 or dual GLP-1/GIP agonists without establishing this causal pathway or systemic geroprotection in humans. [expert-opinion] (novelty: 3)
- 2026-09-28 — Loss ofdisrupts lipid signaling and causes slow muscle fiber degeneration.: Model-organism loss-of-function study [animal-model] reports that Srebp1 loss disrupts lipid mediator signaling and cardiolipin homeostasis, causing selective slow oxidative muscle-fiber degeneration and reduced muscle mass, adding a lipogenic-regulation route to mitochondrial membrane-lipid pathology without establishing a role in human sarcopenia or a therapeutic benefit from SREBP1 activation. [animal-model] (novelty: 3)
- 2026-10-29 — Metabolic exhaustion underlies sarcopenic obesity susceptibility in aging mice as revealed by multi-omics factor analysis.: Aging-mouse multi-omics factor-analysis study [animal-model] links sarcopenic-obesity susceptibility to skeletal-muscle metabolic exhaustion and incomplete β-oxidation rather than obesity severity, identifying circulating acetylcarnitine and pantothenol as a discriminatory signature without establishing human predictive validity or, from the supplied evidence, causality. [animal-model] (novelty: 3)
- 2026-10-20 — From Benefit to Harm: Context-Dependent Responses to Dietary Interventions.: Review synthesis, no new primary data [expert-opinion]: calorie restriction, fasting, and ketogenic diets are described as producing context-dependent benefits or harms, including neurodegeneration or tumor metastasis in susceptible experimental settings, with baseline mitochondrial integrity, immune state, tissue context, and oncogenic alterations proposed as response modifiers rather than established predictors of human outcomes. [expert-opinion] (novelty: 3)
- 2026-10-29 — A stress-adapted fiber state promotes clonal expansion of deleted mitochondrial DNA.: Preclinical muscle-fiber mechanistic study reports that mtDNA depletion induces an Hsp60-high stress-adapted state that initially preserves respiration but subsequently permits deletion formation and supraphysiological clonal expansion of deleted mtDNA, linking depletion to focal deletion accumulation in the studied model without establishing this sequence in human aging. [mechanism-plausible] (novelty: 3)
- 2026-10-08 — Phosphodiesterase 4 inhibitors extend lifespan of C. elegans and attenuate cellular senescence of mouse embryonic fibroblasts.: PDE4 inhibitor preclinical study: roflumilast and rolipram extended C. elegans lifespan and roflumilast improved mitochondrial function and lowered oxidative stress in mouse embryonic fibroblasts via PKA activation — nominates cAMP/PKA elevation (via PDE4 blockade) as an upstream lever on mitochondrial quality in a worm-lifespan + MEF context, no mammalian in vivo bioenergetic endpoint. [animal-model] (novelty: 3)
- 2026-10-10 — THE AGING PURINOME: A PURINERGIC FRAMEWORK LINKING THE HALLMARKS OF AGING TO INFLAMMAGING.: 2026 Aging Purinome review ties mitochondrial NAD+ decline and extracellular ATP/adenosine remodeling into a single purinergic framework, framing bioenergetic failure as both a source (leaked ATP as DAMP) and consequence of age-related purinome imbalance — conceptual synthesis, no new mitochondrial endpoints. [expert-opinion] (novelty: 3)
- 2026-10-05 — K21 Improves Mitochondrial Function in Macrophages, Extending Life in Nematode Worms: News coverage of the already-logged K21 study: antimicrobial silane K21 remodels macrophage mitochondrial metabolism and extends C. elegans lifespan — no new data beyond the primary cell + invertebrate report, no mammalian bioenergetic endpoint. [animal-model] (novelty: 3)
- 2026-09-30 — Targeting Ero1L by Parthenolide Alleviates Cellular Senescence and Fibrosis of Localized Scleroderma by Regulating Mitochondria‐Associated Endoplasmic Reticulum Membranes Stabilization: Preclinical scleroderma study: parthenolide targeting of the ER oxidoreductase Ero1L stabilized MAM contact sites and attenuated mitochondria-ER coupling defects linked to fibroblast senescence and fibrosis, adding a redox-ER-mitochondria interface node to the mito-dysfunction picture in a fibrotic skin disease model. [animal-model] (novelty: 3)
- 2026-10-03 — Elamipretide Rejuvenates Oocyte Quality and Restores Female Fertility During Reproductive Aging: Preclinical reproductive-aging study: the mitochondria-targeted peptide elamipretide (SS-31) rejuvenated oocyte quality and restored female fertility in aged animals, extending the mitochondria-targeted-peptide rescue paradigm (previously logged in cardiac/muscle contexts) into the female germline; no human readout. [animal-model] (novelty: 3)
- 2026-04-03 — A 3-N nose-to-brain urolithin a nanomotor targeting microglial mitophagy in neuroinflammation.: LPS neuroinflammation model: nose-to-brain urolithin A nanomotor reduced oxidative stress and rescued microglial mitochondrial quality control, extending UA-driven mito-rescue to a brain-microglia compartment via intranasal delivery — preclinical, no bioenergetic flux endpoint. [animal-model] (novelty: 3)
- 2026-07-17 — Is Urolithin A(UA) a pharmacologically credible neuro-nutraceutical? A critical review of mechanisms, brain exposure, and evidence gaps in Alzheimer’s and Parkinson’s disease.: 2026 critical review positions Urolithin A as a mitophagy-restoring postbiotic with established human mitochondrial/muscle readouts (prior RCTs in older adults) but no CNS mitochondrial endpoint yet tested in disease trials — synthesis of mixed preclinical and human evidence, no new bioenergetic data. [expert-opinion] (novelty: 3)
- 2026-06-10 — Systemic characterization of aging-related phenotypes induced by wild-type and G2019S LRRK2 in Caenorhabditis elegans.: C. elegans LRRK2-transgenic study: G2019S LRRK2 drove lipid/lipofuscin accumulation and proteostasis failure consistent with mitochondrial-metabolic stress, while WT LRRK2 shifted metabolism toward resistance — adds a kinase-mutation-dependent split in mitochondrial-metabolic phenotypes to the LRRK2 arm of mito-aging biology, no mammalian bioenergetic endpoint. [animal-model] (novelty: 3)
- 2025-11-22 — Nicotinamide riboside supplementation restores microglial health and improves cognition in aged male mice.: Aged male mouse study: 8-week NR (400 mg/kg) restored microglial metabolism toward a younger homeostatic profile alongside cognitive gains, extending NAD-precursor-driven mitochondrial-metabolic rescue from peripheral/muscle contexts into brain-resident innate immune cells; mouse-only, sex-specific (males), no bioenergetic flux endpoint beyond gene-expression inference. [animal-model] (novelty: 3)
- 2026-08-22 — Adaptive and degenerative mitochondrial remodeling define distinct redox states in age-related macular degeneration.: Aged rhesus macaque multi-modal AMD study separates punctate deposits (adaptive mitochondrial remodeling, oxidized redox state) from soft drusen (degenerative remodeling, reduced redox state) and ties a COX3 mtDNA variant to the drusen phenotype — adds an NHP-level, lesion-resolved split of ‘mitochondrial dysfunction in AMD’ into two distinct redox/remodeling trajectories with an mtDNA genetic anchor; no bioenergetic flux endpoint, no human readout. [animal-model] (novelty: 3)
- 2026-09-29 — Condensate-driven triglyceride reduction links α-synuclein to mitochondrial dysfunction.: C. elegans study: α-synuclein lipid binding and condensate formation progressively deplete triglycerides and disrupt lipid droplets and mitochondria during aging, with MCT supplementation or blockade of long-chain unsaturated fatty acid synthesis rescuing toxicity, and a supporting observation of lower plasma TAGs in Parkinson’s disease cohorts — adds a condensate-driven lipid-depletion route to the α-synuclein→mitochondrial-dysfunction axis; worm-level mechanism with a human observational correlate, no human bioenergetic endpoint. [animal-model] (novelty: 3)
- 2026-10-06 — Multimodal Technology-Driven aging Research: Decoding the Mitochondria‒Pyroptosis axis in muscle atrophy and cognitive decline.: 2026 methodological review proposes a cross-scale multimodal technology framework (single-cell/spatial omics + imaging + AI) to trace oxidative mtDNA damage and mitochondrial quality-control failure as the proximal driver of a mitochondria→pyroptosis axis linking muscle atrophy and cognitive decline — synthesis of prior biology, no new mitochondrial endpoints. [expert-opinion] (novelty: 3)
- 2025-11-18 — Age-related changes in synapse ultrastructure and neuroprotective effect of dietary curcumin in the lateral prefrontal cortex layer 3 of the rhesus monkey.: Rhesus monkey LPFC layer 3 EM study: long-term dietary curcumin in middle-aged primates partially preserved mitochondrial ultrastructure alongside spine–PSD synaptic scaling, extending polyphenol-mediated mitochondrial morphology protection into a nonhuman primate brain region tied to cognitive decline — primate preclinical, no bioenergetic flux endpoint or human readout. [animal-model] (novelty: 3)
- 2026-05-28 — Rosiglitazone alleviates Parkinson’s disease phenotypes of Drosophila via dCTP-mediated inhibition of AGE-RAGE pathway.: Drosophila PD rosiglitazone study links AGE-RAGE/EGR1 inhibition (via the drug and its metabolite dCTP) to restored mitochondrial quality control and reduced lipid-droplet accumulation, adding a glycation-signaling upstream input to the mito-quality-control picture — fly-only, no mammalian bioenergetic endpoint. [animal-model] (novelty: 3)
- 2026-04-24 — Mitochondrial Dysfunction and Telomeric Shortening as Long-term Complications After COVID-19.: Prospective post-hospitalization COVID-19 cohort (1–2 year follow-up) reports sustained alterations in leukocyte mitochondrial proteins that track with pulmonary fibrotic sequelae, extending the mitochondrial-dysfunction picture to a specific long-COVID human context — observational, no bioenergetic flux endpoint. [human-observational] (novelty: 3)
- 2026-07-09 — Cyclophilin D (CypD) promotes mitochondrial impairment, synaptic defects, cognitive loss, and tau pathology during aging.: Aged-mouse CypD knockout study (24-month) reports closed mPTP, improved mitochondrial bioenergetics and cognition, preserved synaptic proteins, and reduced caspase-3-cleaved tau versus wild-type — adds genetic support that mPTP opening is a tractable upstream node coupling mitochondrial failure to synaptic and tau pathology in the aging brain. [animal-model] (novelty: 3)
- 2026-07-25 — SIRT3 inhibition promotes age-associated vascular impairment by mediating mitochondrial dysfunction and endothelial-to-mesenchymal transition.: 2026 Sirt3-KO + aged-mouse + senescent HUVEC study: endothelial SIRT3 deficiency produces mitochondrial dysfunction upstream of EndMT and vascular aging, extending SIRT3-dependent mitochondrial redox control (previously logged in tendon) to the vascular endothelium. [animal-model] (novelty: 3)
- 2026-06-13 — Cyanidin chloride activates mitophagy to delay aging via PINK1/parkin pathway.: Preclinical C. elegans + aged mouse study positions PINK1/Parkin-driven mitochondrial clearance (triggered by cyanidin chloride) as the proximal mechanism improving age-related mitochondrial quality control, adding a food-anthocyanidin lever to the selective-mitophagy restoration menu — no mammalian bioenergetic flux endpoint. [animal-model] (novelty: 3)
- 2026-08-18 — The nutrition-sleep-circadian axis in age-related neurodegeneration: Cellular mechanisms, metabolic dysfunction, and neuroprotective interventions.: 2026 integrative review places mitochondrial failure as one of four convergent cellular substrates (with inflammation, proteostasis loss, and gut–brain signaling) through which a disrupted nutrition–sleep–circadian axis accelerates AD/PD-type neurodegeneration — synthesis of prior mechanistic literature, no new mitochondrial endpoints. [expert-opinion] (novelty: 3)
- 2026-09-29 — Mitochondrial membrane lipid cardiolipin controls fiber-type adaptations in aging muscle via estrogen-related receptor γ.: Mouse Crls1/cardiolipin study positions an inner-membrane lipid (not an OXPHOS protein) as a causal upstream driver of aging-muscle fiber-type shifts via ERRγ retrograde signaling, with Crls1 restoration reversing atrophy and premature mortality — extends the mitochondrial-aging picture into membrane-lipid composition as a tractable node. [animal-model] (novelty: 4)
- 2026-05-25 — A sustained NADsupplementation-biosynthesis nanoplatform for metabolic restoration in aged bone regeneration.: 2026 preclinical bone-regeneration study: a sustained NAD supplementation-biosynthesis nanoplatform (N/S@M@P) restored NAD/NADH ratio and ATP in senescent BMSCs and improved aged bone defect healing — adds a dual-mode (precursor supply + biosynthetic enzyme support) local-delivery approach to the NAD-restoration arm of mitochondrial-aging biology, no human data. [animal-model] (novelty: 3)
- 2026-07-08 — The autophagy-senescence-inflammasome axis: A novel triad in neurodegenerative diseases?: 2026 ASI-axis review implicates damaged mitochondria (mtDNA/mtROS release from failed mitophagy) as a proximal priming signal for inflammasome activation within the proposed Autophagy–Senescence–Inflammasome triad in neurodegeneration — framing claim, no new mitochondrial endpoints. [expert-opinion] (novelty: 3)
- 2026-08-02 — Brain aging clocks: From methodological advances to cellular mechanisms.: 2026 brain aging clocks review includes mitochondrial dysfunction among the cellular mechanisms linked to accelerated neural aging by cellular-resolution brain clocks, framing bioenergetic decline as one of several substrates the clocks aim to resolve; synthesis-level, no new mitochondrial endpoints. [expert-opinion] (novelty: 3)
- 2026-09-28 — Stress-Induced Senescence of Human Umbilical Cord Mesenchymal Stromal Cells Caused by Mitomycin C.: In vitro UC-MSC mitomycin C study characterizes a p53/p21/p27 DDR-driven arrest in perinatal MSCs with no explicit mitochondrial-function endpoint; touches the mito page only tangentially via the nuclear-DDR-centric nature of the response rather than mitochondrial injury. [mechanism-plausible] (novelty: 3)
- 2026-07-07 — Lactylation in the ageing nervous system: Epi-metabolic regulation, disease mechanisms, and translational challenges.: 2026 Kla-in-ageing-CNS review positions age-related lactate accumulation (partly from mitochondrial OXPHOS decline and glycolytic shift) as the metabolic substrate feeding histone/non-histone lactylation, framing bioenergetic failure not only as energy loss but as a source of epigenetic signal via lactate — conceptual framing, no mitochondrial-flux data. [expert-opinion] (novelty: 3)
- 2026-08-10 — Chronic subdural hematoma through the hallmarks of aging: a geroscience framework for the commonest neurosurgical condition of older adults.: 2026 CSDH geroscience minireview lists mitochondrial dysfunction among the twelve hallmarks mapped onto chronic subdural hematoma pathogenesis as a secondary (weaker) contributor relative to chronic inflammation and altered intercellular communication — framing claim, no mitochondrial measurements in CSDH tissue. [expert-opinion] (novelty: 3)
- 2026-10-01 — Hepatocyte Growth Hormone Receptor Ablation Is Associated With Aging Phenotypes and Hepatic Mitochondrial Dysfunction.: cross-connection with hepatic-ghr-signaling: Hepatocyte-autonomous GHR loss drives hepatic mitochondrial dysfunction via PPARγ–PDK4/CD36, nominating PDK4 as a druggable node where the GH axis meets mitochondrial substrate handling in aging liver. (novelty: 3)
- 2026-07-13 — PFDA exposure promotes myocardial aging and fibrosis via hyperactivation of the MTORC1 signaling axis.: 2026 preclinical PFDA study implicates mitochondrial dysfunction as a proximal cardiomyocyte lesion downstream of PFAS exposure, feeding MTORC1 hyperactivation, inflammation, and senescence-driven myocardial fibrosis — adds a persistent organic pollutant to the environmental triggers of cardiac mitochondrial failure. [animal-model] (novelty: 3)
- 2026-07-24 — Circulating factors induced by time-restricted eating drive metabolic reprogramming in endothelial cells.: TRE-donor human serum applied to cerebromicrovascular endothelial cells drove OXPHOS remodeling alongside ISR/ATF4 activation and GDF15 induction, consistent with a mitohormesis-like endothelial bioenergetic reprogramming downstream of circulating fasting-induced factors — ex vivo cell culture, no respirometry or in vivo bioenergetic endpoint. [mechanism-plausible] (novelty: 3)
- 2025-12-12 — Elevated mtDNA copy number in older adults is linked to methylation of mitochondrial and nuclear regulatory regions.: Human blood-cell observational study (newborns to age 96) found mtDNA copy number rises with age, especially after 45, correlating with methylation of the mtDNA control region and the POLGA promoter — adds a human cross-sectional link between age-related mtDNAcn increase and epigenetic regulation of mitochondrial biogenesis machinery. [human-observational] (novelty: 3)
- 2026-05-26 — A taxifolin-zinc nanozyme with SOD-like activity attenuates oxidative-stress-induced senescence and extends lifespan in C. elegans.: 2026 preclinical nanozyme study: a taxifolin–zinc nanozyme with SOD-like catalytic activity attenuated oxidative stress in cells and extended C. elegans lifespan, nominating a metal-coordinated flavonoid as a SOD-mimetic approach to buffering mitochondrial ROS — worm/cell level only, no mammalian bioenergetic endpoint. [animal-model] (novelty: 3)
- 2026-02-04 — Environmentally relevant concentrations of DCOIT impaired lifespan and healthspan in Caenorhabditis elegans.: C. elegans exposure study: environmentally relevant concentrations of the antifouling biocide DCOIT shortened lifespan and healthspan via comt-4 upregulation that depleted dopamine and drove oxidative stress, with comt-4 RNAi or the COMT inhibitor opicapone rescuing the phenotype — adds a xenobiotic-catecholamine-metabolism route into the oxidative-stress arm of mitochondrial aging, worm-only. [animal-model] (novelty: 3)
- 2026-01-26 — High-protein diet promotes aging by activating the CG6415/AMT gene and disrupting mitochondrial homeostasis.: Drosophila multi-omics + human-cell follow-up: high-protein diet (isoleucine as key amino acid) activates CG6415/AMT, which inhibits oxidative phosphorylation and disrupts mitochondrial homeostasis upstream of p53–p21 aging signaling — adds a dietary-amino-acid→AMT→OXPHOS node to the mitochondrial-aging picture; preclinical with limited human-cell confirmation. [animal-model] (novelty: 3)
- 2026-10-01 — Traditional Chinese Medicine Formulas in Delaying Aging: From Theoretical Foundations to Molecular Mechanisms and Translational Perspectives.: 2026 TCM-formulas-and-aging review positions multi-herb TCM formulas as acting partly through mitochondrial-homeostasis restoration (biogenesis, dynamics, mitophagy) across aging hallmarks, cataloging preclinical formula effects without new mitochondrial-flux data; proposes network pharmacology + AI target screening to resolve which components drive the mito signal. [expert-opinion] (novelty: 3)
- 2026-09-24 — Targeting Glial Glycolysis with EGCG Alleviates Parkinson’s Disease in a PINK1 mutant Drosophila Model.: Drosophila PINK1-mutant PD study: EGCG rescue operates via glial glycolysis suppression and lactate-driven neuroinflammation rather than restored neuronal mitochondrial quality control, suggesting PINK1-loss neurodegeneration phenotypes can be uncoupled from the neuron-intrinsic mitochondrial lesion via a glial metabolic detour — fly-only, no direct bioenergetic endpoint. [animal-model] (novelty: 3)
- 2026-09-12 — Soluble pathogenic tau transmission to astrocytes drives acute oxidative damage, cellular senescence, and neurovascular uncoupling in a model of Alzheimers tauopathy: 2026 tauopathy-model preclinical study: soluble tau oligomers entering astrocytes acutely impair mitochondrial function and elevate oxidative damage as the proximal lesion upstream of astrocyte senescence and neurovascular uncoupling — adds tau-driven astrocyte mitochondrial injury to the CNS mito-dysfunction roster. [animal-model] (novelty: 3)
- 2026-09-25 — Fisetin to Improve Vascular Function in Older Adults: 2026 pilot RCT protocol of intermittent fisetin in older adults specifies mitochondrial oxidative stress as a hypothesized mediator of vascular improvement, adding a fisetin-arm to the mito-ROS-directed human trial roster alongside MitoQ Mito-Frail — protocol only, no results. [human-rct] (novelty: 3)
- 2026-09-24 — Giving Cells Fresh Mitochondria Helps Clear Damaged Ones: Press coverage of the already-logged Aging Cell rat/mouse study framing age-elevated BNIP3 as a driver of cardiac mitochondrial energy-handling defects reversed by mitochondrial transplantation — no new data beyond the primary preclinical report. [animal-model] (novelty: 3)
- 2026-09-23 — Mitochondrial Transplantation Rejuvenates Aging Heart by Restoring Mitophagy Flux via the HIF‐3α‐BNIP3 Axis: Aging Cell rat/mouse study: mitochondrial transplantation into aged hearts restored mitophagy flux and rejuvenated cardiac function via a HIF-3α–BNIP3 axis, adding an exogenous-organelle-delivery route to the age-related mitochondrial-decline picture; preclinical only. [animal-model] (novelty: 3)
- 2026-09-26 — Hepatocyte Growth Hormone Receptor Ablation Is Associated With Aging Phenotypes and Hepatic Mitochondrial Dysfunction: Mouse hepatocyte-specific GHR knockout linked loss of liver GH signaling to hepatic mitochondrial dysfunction alongside broader aging phenotypes, adding a tissue-autonomous GH-axis input to the age-related mitochondrial-decline picture. [animal-model] (novelty: 3)
- 2026-09-12 — Age-related IGF-1 decline permits a redox-sensitive transcriptional shift that directs hematopoiesis toward a CCR2myeloid fate.: Preclinical HSC study invokes an oxidative-stress/redox-sensitive transcriptional switch downstream of bone-marrow IGF-1 decline as the mechanism gating myeloid fate bias, tying redox tone (not directly measured as mitochondrial flux) to hematopoietic aging trajectory. [mechanism-plausible] (novelty: 3)
- 2026-09-19 — 3D-Printed and Biofabricated Scaffolds for Osteoporotic Bone Defect Repair: Mechanical Adaptation, Redox Control, Senescence Modulation and Osteoimmunomodulation.: 2026 osteoporotic-scaffold review nominates redox control as a scaffold-design axis, invoking mitochondrial ROS and impaired antioxidant defense in aged osteoblasts/BMSCs as the substrate that scaffolds should buffer via ROS-scavenging coatings and cargos — conceptual/synthesis, no new mitochondrial-flux measurements. [expert-opinion] (novelty: 3)
- 2026-09-18 — Associations of single and combined exposure to plasma metals with biological aging in Chinese adults: Mediation by inflammation and oxidative stress and moderation by diabetes.: 2026 Chinese cross-sectional plasma-metals study (n=3055) implicates oxidative-stress markers as partial mediators of the plasma-metal (Cu/Se/Sb)–biological-age association, consistent with mitochondrial ROS as a downstream node linking metal exposure to accelerated aging — human observational, no direct mitochondrial-flux endpoint. [human-observational] (novelty: 3)
- 2026-08-29 — NADprecursor treatment prevents cardiomyopathy but disrupts erythroid maturation in mitochondrial progeria.: Chronic nicotinamide riboside in mitochondrial mutator (POLG) mice prevented cardiomyopathy in postmitotic heart tissue but induced bone-marrow reductive stress that disrupted erythroid maturation and worsened anemia — a tissue-specific dual outcome cautioning that NAD-precursor supplementation can act as a rescue in one aged mitochondrial compartment and a stressor in another. [animal-model] (novelty: 3)
- 2026-09-25 — An RNA thermogenic therapy to preserve lean mass and enhance metabolic health during GLP-1 weight loss.: Mouse ASO study: ZFP423 knockdown in adipose induced beiging with implied increases in uncoupled mitochondrial respiration/thermogenic capacity, adding a transcriptional-derepression lever to the adipose-mitochondrial-biogenesis picture; no direct respirometry or human readout, and mitochondrial effects are inferred from the thermogenic phenotype. [animal-model] (novelty: 4)
- 2026-09-01 — MGRN1 preserves transiently damaged mitochondria for antioxidant-mediated repair.: Cell-based study identifies MGRN1 as a damage-threshold sensor that restrains mitophagy on transiently damaged mitochondria, licensing an antioxidant repair program (DELE1–eIF2α–ATF4, Nrf2, JUN/FOS) that restores organelle function — adds a repair-vs-clearance checkpoint to the mitochondrial quality-control picture; preclinical cell-level only. [mechanism-plausible] (novelty: 3)
- 2026-09-15 — Cuproptosis in age-related orthopedic diseases: mechanisms and therapeutic prospects.: 2026 cuproptosis-in-orthopedic-aging review situates copper-dependent mitochondrial cell death (lipoylated TCA-protein aggregation + Fe–S cluster destabilization) as a distinct mitochondria-centered death modality contributing to skeletal-cell loss in OA, OP, and IVDD, adding a metal-triggered proteotoxic bioenergetic-collapse route to the mitochondrial-aging picture — narrative synthesis, no primary mitochondrial-flux data. [expert-opinion] (novelty: 3)
- 2026-09-17 — Drug-induced metabolic remodeling promotes antimicrobial activity in macrophages and extends longevity in vivo.: K21 silane antimicrobial reprograms macrophage mitochondrial metabolism (mitophagy-linked remodeling) and extends lifespan in an invertebrate model, adding a small-molecule antimicrobial to the mito-remodeling-for-longevity roster — preclinical cell + model-organism, no mammalian bioenergetic endpoint. [animal-model] (novelty: 3)
- 2026-09-19 — Mitochondrial Calcium Sensor Tusc2 Protects the Aging Hippocampus from Proteostasis Collapse in a Sex-Specific Manner.: Tusc2 knockout mouse study: loss of the mitochondrial calcium sensor Tusc2 drives hippocampal mitochondrial dysfunction with sex-specific severity (worse in males) and transcriptomic overlap with human brain aging, adding a mito-Ca²⁺-sensing input to age-related bioenergetic decline in a brain region. [animal-model] (novelty: 3)
- 2026-09-20 — NAD-sirtuin-mitochondrial quality control in lens epithelial cells: a candidate modulatory network in crystalline lens aging.: 2026 evidence-stratified review nominates lens epithelial cell mitochondrial quality control (coupled to NAD/sirtuin tone) as a candidate proximal lesion in crystalline lens aging (cataract/presbyopia), while flagging that an age-dependent NAD change in normal human LECs and a causal epithelial-to-tissue pathway remain unproven — conceptual framing extending mitochondrial-aging biology to a specific ocular compartment, no primary mitochondrial-flux data. [expert-opinion] (novelty: 3)
- 2026-09-20 — Aging-associated loss of CPEB4 impairs mitochondrial adaptation and promotes stress-induced senescence in alveolar type II cells.: 2026 preclinical AT2-cell study: age-related CPEB4 decline lowers TP53INP2 and blunts mitochondrial adaptation to stress in alveolar type II cells, adding a CPEB4–TP53INP2 post-transcriptional axis to the age-related loss of mitochondrial adaptability picture — mouse/cell-level, no human readout. [animal-model] (novelty: 3)
- 2026-09-22 — Asb2-KIF11 Axis Protects Against Heart Failure by Restoring Lysosomal Distribution and Mitochondrial Homeostasis.: Mouse cardiomyocyte study nominates Asb2-mediated ubiquitination of KIF11 as an upstream regulator of lysosomal positioning that gates autophagic clearance of damaged mitochondria, with Asb2 restoration or KIF11 inhibition reversing mitochondrial-homeostasis loss in age- and pressure-overload heart failure — preclinical, no human cardiac endpoint. [animal-model] (novelty: 3)
- 2026-09-22 — Modeling pancreatic islet aging: mitochondrial dysfunction and functional rescue in 3D organoids by exogenous mitochondrial delivery.: 3D senescent pancreatic islet organoid model: exogenous mitochondrial delivery restored mitochondrial membrane potential and partially rescued glucose-stimulated insulin secretion, offering a preclinical proof-of-concept that mitochondrial transplantation can reverse a functional bioenergetic deficit tied to lost glucokinase/GSIS machinery — organoid-only, no in vivo or human data. [mechanism-plausible] (novelty: 3)
- 2026-09-23 — Mitophagy-Related Gene Dysregulation: Links With Telomere Attrition and Impaired Lung Function in Sulfur Mustard-Exposed Veterans.: Sulfur-mustard veteran cohort reports dysregulated mitochondrial dynamics/mitophagy gene expression (DRP1, FIS1, PINK1, PRKN) co-varying with telomere shortening and reduced FVC/FEV1, extending toxicant-driven mitochondrial-quality-control failure to a chronic-exposure human population — transcript-level, no functional bioenergetic or flux endpoint. [human-observational] (novelty: 3)
- 2026-09-15 — Multiparametricmapping reveals tissue-specific mitochondrial aging trajectories.: Multiparametric 2p-FLIM + MitoSLIT live-imaging study demonstrates that mitochondrial aging follows tissue-specific and even subcellular (soma vs axon) trajectories rather than converging on a uniform bioenergetic endpoint — methodological/preclinical evidence reinforcing the ‘homeodynamic, tissue-specific’ reframing over single-metric decline. [animal-model] (novelty: 3)
- 2026-09-14 — MA-5 attenuates disease-associated transcriptomic aging and pathological microglial states in Gaucher disease.: Preclinical Gaucher disease study (mouse + patient iPSC): mitonic acid-5 (MA-5) preserved mitochondrial cristae architecture and suppressed mtDNA leakage into the cytosol, positioning cristae integrity as an upstream lever on the mtDNA→cGAS–STING/NLRP3 inflammatory axis in a lysosomal storage disease with accelerated-aging features. [animal-model] (novelty: 3)
- 2026-09-25 — The Interplay of Metabolic Dysfunction, Neuroinflammation, and Mitochondrial Dysfunction in Balance Impairment: Insights from Type 2 Diabetes Mellitus and Alzheimer’s Disease.: 2026 narrative review positions mitochondrial failure (bioenergetic collapse, mtROS, mtDNA leak) as one leg of a self-reinforcing insulin-resistance/glucotoxicity–NLRP3 neuroinflammation–mitochondrial cycle driving balance impairment across type 2 diabetes and Alzheimer’s disease, targeting motor circuits and peripheral nerve/muscle — synthesis only, no new mitochondrial endpoints. [expert-opinion] (novelty: 3)
- 2026-09-20 — Modulating Ubiquinone Biosynthesis Rescues Mitochondrial Dysfunction by Genetic Interaction in a Phosphatidylethanolamine (PE)-Deficient Disease Model.: C. elegans PSD-1 knockdown (PE-deficient) disease model: co-modulating ubiquinone biosynthesis/ETC function rescued shortened lifespan, oxygen consumption, and mitochondrial defects, arguing the pathology is driven by ETC-mediated retrograde signaling rather than phospholipid loss per se — worm-only genetic-interaction evidence, no mammalian readout. [animal-model] (novelty: 3)
- 2026-09-27 — Grtp1 Safeguards Against Paternal Reproductive Aging and Intergenerational Behavioral Deficits by Preserving Redox Homeostasis.: Mouse germline study invokes PRDX1/4 and TXN as GRTP1-dependent redox buffers in aging sperm, indirectly implicating mitochondrial ROS handling in the male germ line but without a mitochondrial-flux endpoint. [animal-model] (novelty: 3)
- 2026-09-16 — Quantitative proteomics reveals coordinated changes in the proteome during replicative senescence.: 2026 replicative-senescence proteomics identifies coordinated mitochondrial protein insolubility as a core feature of the senescent proteome, linking mitochondrial proteostasis failure (aggregation/insolubility rather than just OXPHOS decline) to the broader senescent remodeling — cell-culture only, no functional respiration or in vivo readout. [mechanism-plausible] (novelty: 3)
- 2026-09-23 — Engineered Extracellular Vesicle Revitalizing Macrophage Energy Metabolism for Aged Wound Repair.: 2026 mouse wound-healing study: 4OI-loaded extracellular vesicles restored macrophage mitochondrial function by rescuing ASS1-driven arginine metabolism and oxidative phosphorylation in aged and diabetic wound beds, linking an arginine–OXPHOS axis to mitochondrial rejuvenation in tissue macrophages — preclinical only, no human data. [animal-model] (novelty: 3)
- 2026-09-24 — Impact of supervised physical exercise on inflammatory and oxidative stress biomarkers in older adults: a systematic review and meta-analysis of randomized controlled trials.: 2026 meta-analysis of 50 supervised-exercise RCTs in older adults (n=4,379) reports limited and inconsistent improvements in circulating redox/oxidative-stress biomarkers despite modest anti-inflammatory effects — tempers the expectation that exercise reliably shifts systemic redox readouts tied to mitochondrial ROS. [human-rct] (novelty: 3)
- 2026-05-15 — Jintiange ameliorates age-related sarcopenia by inhibiting the cGAS-STING signaling pathway via maintaining mitochondrial homeostasis.: 2026 aged-mouse Jintiange study nominates restoration of skeletal-muscle mitochondrial homeostasis (reduced mtDNA leakage) as the proximal mechanism by which an oral TCM formulation improves muscle mass, strength, and endurance and lastingly ameliorates sarcopenia — mouse-only, no direct mitochondrial-flux endpoint in humans. [animal-model] (novelty: 3)
- 2026-08-24 — Form and function of actin impacts actin health and aging.: Actin-perturbation model-organism study reports that disrupting actin or actin-binding proteins worsens multiple aging hallmarks including mitochondrial-related phenotypes, providing perturbation-level (not just correlative) support that cytoskeletal integrity gates mitochondrial decline — no direct mitochondrial-flux endpoint. [animal-model] (novelty: 3)
- 2026-09-23 — A probioticconverts hesperidin to bioactive hesperetin and improves metabolic dysfunction in aging mice.: 2026 aging-mouse study: probiotic-generated hesperetin engaged CISD2 (an ER–mitochondria contact-site regulator) and SIRT1, with improved hepatic steatosis and grip strength implicating mitochondrial/metabolic rescue as part of the mechanism — no direct mitochondrial-flux endpoint, preclinical. [animal-model] (novelty: 3)
- 2026-09-18 — Ferroptosis and Ferro-Aging in Obesity: Bibliometric Mapping, Shared Mechanisms, and Translational Perspectives.: 2026 obesity–ferroptosis review implicates mitochondrial iron overload and mitochondrial lipid peroxidation as proximal mediators of the ferroptosis-to-ferro-aging continuum in obese tissues, positioning mito-iron/redox handling alongside ACSL4 and Nrf2–GPX4 as candidate nodes — synthesis, no new mitochondrial endpoints. [expert-opinion] (novelty: 3)
- 2026-09-18 — Selenium Deficiency is a Significant Risk Factor for Sarcopenia: Evidence and Selenoprotein-Mediated Mechanisms.: 2026 selenium–sarcopenia review implicates selenoprotein-dependent redox control (GPX4, SELENOT/N) in maintaining muscle mitochondrial redox homeostasis, adding a trace-element/selenoprotein input to the aging-muscle mitochondrial-dysfunction picture; consolidates epi/clinical/animal evidence without a mitochondrial-flux endpoint. [human-observational] (novelty: 3)
- 2026-09-18 — Imeglimin provides dual hepatic and skeletal muscle protection in experimental MASH-associated sarcopenia.: MASH-sarcopenia mouse + myotube study: imeglimin (antidiabetic mitochondrial modulator) restored skeletal-muscle and hepatic mitochondrial function alongside preserved muscle mass and reduced liver injury, adding a dual-tissue mitochondrial-rescue readout for an established clinical drug — preclinical only, no human sarcopenia endpoint. [animal-model] (novelty: 3) [animal-model] (novelty: 3)
- 2026-06-05 — Endurance exercise improves age- and obesity-related cardiac dysfunction and locomotor impairment through muscle Gγ1 gene in Drosophila.: Drosophila endurance-exercise study: muscle Gγ1 upregulation engages Sir2/PGC-1α to reduce lipid toxicity and mitochondrial dysfunction, improving cardiac and locomotor aging phenotypes; Gγ1 knockdown worsens them — fly-only mechanistic link between exercise and mitochondrial biogenesis via a G-protein γ subunit. [animal-model] (novelty: 3)
- 2026-09-18 — Lifelong Caloric Restriction Reshapes Age-Related Hepatic Oxylipin Profiles and Is Associated with a CYB5R3-Linked Epoxide-Diol Signature.: 2026 mouse liver study links lifelong caloric restriction to a CYB5R3-associated epoxide-diol oxylipin signature and improved metabolic profile, tying a plasma-membrane redox enzyme implicated in CR biology to preserved CYP/sEH-derived lipid signaling in aged liver — preclinical, no direct mitochondrial-flux endpoint. [animal-model] (novelty: 3)
- 2026-09-09 — SIRT3-dependent mitochondrial redox homeostasis protects against age-related tendon degeneration.: 2026 murine tendon study: age-related SIRT3 loss impairs mitochondrial redox homeostasis in supraspinatus tenocytes (SOD2 downregulation, ROS elevation), extending mitochondrial-aging biology to tendon tissue with a SIRT3–SOD2/Nrf2 rescue axis — preclinical, no human readout. [animal-model] (novelty: 3) [animal-model] (novelty: 3)
- 2026-09-09 — The redox architecture of gestational diabetes mellitus: from cellular stress engine to epigenetic and mitochondrial rewiring.: 2026 GDM redox review frames placental and offspring mitochondrial programming (bioenergetic reprogramming, mtDNA damage, altered dynamics) as a persistent ‘metabolic memory’ route by which gestational oxidative stress drives maternal accelerated biological aging and multi-organ offspring disease trajectories — narrative synthesis, limited direct human interventional causal data. [expert-opinion] (novelty: 3)
- 2026-09-11 — Preserved mitochondrial respiration in presence of oxidative stress and reduced mitochondrial mass after 10-day bed rest in older adults.: Small controlled 10-day bed-rest study in healthy older men: skeletal-muscle mitochondrial ROS emission rose and mitochondrial mass fell while respiratory capacity was preserved, with OXPHOS transcripts downregulated — places redox imbalance upstream of respiratory failure in disuse-driven mitochondrial decline. [human-rct] (novelty: 3)
- 2026-09-10 — Mitochondria-targeted esculetin mitigates age-associated cardiac remodeling through coordinated activation of AMPK-SIRT1 and inhibition of p38 MAPK signaling.: 2026 aged/ApoE mouse + cardiomyocyte study: mitochondria-targeted esculetin (Mito-Esc) attenuates cardiac mitochondrial dysfunction alongside hypertrophy, fibrosis, and senescence via AMPK–SIRT1 activation and p38 MAPK inhibition, with effects comparable to metformin — adds a mitochondria-targeted coumarin scaffold to the AMPK/SIRT1-engaging mito-directed compound roster, no human data. [animal-model] (novelty: 3)
- 2026-08-28 — Senescent cells maintain viability through adhesion-dependent fragmentation that promotes debris deposition.: 2026 preclinical SCAF study proposes that damaged mitochondria are packaged into adhesion-dependent shed fragments from senescent cells and released extracellularly, adding a cell-non-autonomous disposal route for dysfunctional mitochondria distinct from mitophagy or mitochondrial transfer. [mechanism-plausible] (novelty: 4)
- 2026-09-10 — Mitochondrial homeodynamics in ageing: mechanisms, resilience, and interventions.: 2026 systems-level review reframes mitochondrial aging as tissue-specific erosion of homeodynamic capacities (maintenance, adaptation, recovery) rather than single-pathway failure; grades exercise as the strongest human-evidenced intervention and notes no mitochondrial therapy has been shown to slow aging in healthy humans — narrative synthesis, no new primary data. [expert-opinion] (novelty: 3)
- 2026-09-11 — Mitochondrial homeostasis in musculoskeletal diseases: From pathogenic mechanisms to precision therapies.: 2026 musculoskeletal-mitochondria review unifies osteoporosis, osteoarthritis, and rheumatoid arthritis under shared mitochondrial-homeostasis failure (biogenesis, dynamics, mitophagy, mtDNA leakage) and maps a precision-therapy landscape (MitoQ/SkQ1, metformin, NAD+ boosters, urolithin A, Mdivi-1, senolytics, mitochondrial transplantation) matched to specific defects — narrative synthesis, no new primary data. [expert-opinion] (novelty: 3)
- 2026-09-11 — Replicative and Air Pollution-Induced Senescence: Telomere Dysfunction, Mitochondrial Stress, and Modulatory Effects of Astragaloside IV in Endothelial and Vascular Smooth Muscle Cells.: 2026 in vitro study: PM2.5 exposure induced mitochondrial impairment in human endothelial and vascular smooth muscle cells, coupled to telomere dysfunction and senescence entry; Astragaloside IV partially rescued endothelial mitochondrial phenotypes with limited effect in VSMCs — cell-culture-level evidence linking a common air-pollution exposure to vascular-cell mitochondrial stress. [mechanism-plausible] (novelty: 3)
- 2026-07-15 — Cinnamon polysaccharides reshape gut microbiota and enrich Alloprevotella rava to promote acetate-dependent choline metabolism and delay mammary aging.: 2026 mouse study: microbiota-derived acetate (via Alloprevotella rava enriched by cinnamon polysaccharides) improved host choline metabolism and mammary mitochondrial function, adding an SCFA→one-carbon→mitochondria route to the gut–bioenergetics picture — mouse only, no mammalian mitochondrial-flux endpoint in humans. [animal-model] (novelty: 3)
- 2026-08-24 — Qinghuang powder ameliorates cellular senescence and energy metabolism abnormalities in bone marrow mesenchymal stem cells of myelodysplastic syndromes.: 2026 in vitro MDS-BMMSC study: AsS and indirubin (Qinghuang powder core components) ameliorated energy-metabolism abnormalities in patient-derived stromal cells with AMPK activation implicated as the proximal bioenergetic switch, adding a TCM-compound entry to the AMPK/mitochondrial-remodeling roster — cell-culture only, no functional mitochondrial or in vivo endpoints. [mechanism-plausible] (novelty: 3)
- 2026-08-05 — Mitochondrial-targeted Antioxidant Supplementation for Improving Age-related Vascular Dysfunction in Humans: MitoQ vascular-aging RCT protocol (20 mg/day oral MitoQ, 3 months, n=56/group, adults ≥60) will test whether mitochondria-targeted antioxidant reduces mtROS enough to improve endothelial function and aortic stiffness — protocol/aims only, no readout yet. [human-rct] (novelty: 3)
- 2026-05-07 — FMO1 disrupts mitochondrial functional homeostasis through ROS-mediated mechanisms to drive chondrocyte senescence and hypertrophy.: 2026 preclinical chondrocyte study nominates FMO1 as an upstream driver of ROS elevation and mitochondrial fission bias, coupling a flavin monooxygenase to age-related mitochondrial dynamic imbalance in cartilage cells; FMO1 inhibition restores mitochondrial homeostasis. [animal-model] (novelty: 3)
- 2026-09-01 — NADMetabolic Reprogramming Drives CD8T Cells Senescence and Exacerbates Ulcerative Colitis.: 2026 UC mouse + human study places NAD metabolic dysregulation upstream of CD8 T-cell mitochondrial dysfunction with mtDNA leakage into the cytosol, coupling immune-cell bioenergetic failure to cGAS–STING-driven senescence in a colitis context. [animal-model] (novelty: 3)
- 2026-09-09 — Copper and iron engage distinct metabolic programs for cellular survival.: Yeast study implicates copper- and iron-dependent metabolic programs (AMPK/antioxidant vs TORC1-permissive) in maintaining long-term cellular survival, extending the trace-metal→bioenergetic-resilience picture to distinct nutrient-sensing arms — mechanistic, yeast only, no mammalian mitochondrial endpoint. [animal-model] (novelty: 3)
- 2026-08-14 — Targeting TWEAK to enhance mitochondrial biogenesis and attenuate age-related muscle mass loss.: C2C12 + aged-mouse AAV study: TWEAK knockdown enhances mitochondrial biogenesis in aged skeletal muscle via AMPK activation, positioning the TWEAK/Fn14 cytokine axis as an upstream suppressor of muscle mitochondrial biogenesis — preclinical mechanism, no functional strength benefit shown. [animal-model] (novelty: 3)
- 2026-07-29 — Aging Resilience Through Microbiota Optimization and Regulation: Planned young-donor FMT trial in older adults includes metabolic-function endpoints that indirectly probe the gut-microbiota→bioenergetic-decline axis, but no mitochondrial-specific readout is prespecified — protocol only. [human-rct] (novelty: 3)
- 2026-08-12 — The Mito-Frail Trial: Effects of MitoQ on Vasodilation, Mobility and Cognitive Performance in Frail Older Adults: Mito-Frail: early-phase RCT protocol testing MitoQ (mitochondria-targeted CoQ10) in frail older adults with vascular, mobility, and cognitive endpoints — protocol/aims only, no readout yet. [human-rct] (novelty: 3)
- 2026-08-21 — Aged Mitochondrial DNA Is Associated With Aberrant Acute Exercise‐Induced Redox Responses in Human Skeletal Muscle: Human skeletal-muscle observational study links aged mtDNA to aberrant acute exercise-induced redox responses, adding in-human evidence that mtDNA aging alters the redox signaling of an acute exercise bout — cross-sectional/observational, not interventional. [human-observational] (novelty: 3)
- 2026-08-28 — Oxygenaging: A Physiological Framework for Geroscience: Aging Cell ‘Oxygenaging’ framework situates mitochondrial oxygen utilization and ETC-linked bioenergetic decline within a broader oxygen-physiology lens for aging, reframing mito dysfunction as one node in an integrated oxygen-handling axis — conceptual synthesis, no new mitochondrial endpoints. [expert-opinion] (novelty: 3)
- 2025-11-22 — Exploring the role of β2-microglobulin in the relationship between physical activity and DNAm-predicted PhenoAge: Evidence from a population-based and mice single-cell RNA-sequencing study.: Companion mouse scRNA-seq to the β2M/PA mediation study identifies exercise-associated changes in β2M expression and immune–mitochondrial pathway co-regulation, offering preclinical support that exercise engages coupled immune and mitochondrial transcriptional programs — mouse-only, no in vivo mitochondrial-flux endpoint. [animal-model] (novelty: 3)
- 2026-04-13 — The metabolic-inflammatory axis in aging: A multi-organ framework anchored in Sarcopenia - A review.: 2026 GLAM-framework review invokes mtROS–p53 as a shared cross-organ module linking mitochondrial stress in muscle, liver, and adipose to systemic metabolic-inflammatory aging — conceptual framing, no new mitochondrial endpoints. [expert-opinion] (novelty: 3)
- 2026-05-30 — Cell senescence in chronic pain: An integrative perspective on cellular and neural mechanisms.: 2026 chronic-pain review names mitochondrial dysfunction in pain-processing cells as an upstream contributor to the senescence program sustaining chronic pain, adding neuropathic-pain circuitry to the tissue contexts where mito failure feeds SASP — conceptual framing, no new mitochondrial endpoints. [expert-opinion] (novelty: 3)
- 2026-06-08 — Hormetic fasting extends Caenorhabditis elegans lifespan via H3K27 acetylation of lipid catabolism and antioxidant genes.: C. elegans hormetic-fasting study links stress-induced fatty-acid oxidation to lifelong antioxidant gene induction via H3K27ac, positioning transient mitochondrial ROS from lipid catabolism as the hormetic trigger for a durable redox-defense program — mitohormesis mechanism, nematode only. [animal-model] (novelty: 3)
- 2026-06-24 — FUBL-3/FUBP1 mediates mitochondrial stress-induced chromatin remodeling and longevity.: C. elegans forward-genetic screen identifies FUBL-3 (homolog of human FUBP1) as a nuclear effector that translocates upon mitochondrial stress to remodel chromatin at proteostasis/quality-control loci, activate UPRmt, and extend lifespan, with human FUBP1 rescuing the worm phenotype — adds a conserved mito-to-nuclear communicator to the mitochondrial-dysfunction picture, worm-level with cross-species rescue only. [animal-model] (novelty: 4)
- 2026-06-27 — Co-exposure to environmental lead and hypertension exacerbates anxiety and depression via mtDNA-mediated cGAS phase separation.: 2026 mouse study nominates astrocyte mitochondrial injury with cytosolic mtDNA leakage as the proximal lesion coupling environmental lead + hypertension co-exposure to cGAS-driven senescence in the prefrontal cortex. [animal-model] (novelty: 3)
- 2026-07-05 — A Melatonin-Catechol Hybrid Molecule Prolongs Lifespan via Regulating ROS and Reprogramming Mitochondrial Metabolism.: Preclinical (cells + model organism) study of MC1, a melatonin–catechol hybrid, reports lifespan extension and improved muscle strength alongside reprogrammed mitochondrial metabolism and differential ROS regulation — adds a hybrid-compound entry to the mito-ROS reprogramming toolbox, no mammalian outcome data. [animal-model] (novelty: 3)
- 2026-07-01 — The Molecular Basis of Ocular Aging: Mechanisms, Pathologies, and Emerging Therapeutics.: 2026 ocular-aging review names mitochondrial dysfunction (RPE bioenergetic collapse, TM oxidative injury) as one of four convergent hallmarks driving age-related eye disease, with NAD+ metabolism and mitochondria-targeted agents nominated as candidate interventions — conceptual framing, no new mitochondrial endpoints. [expert-opinion] (novelty: 3)
- 2026-07-10 — ASAP3 deficiency alleviates hepatic senescence and correlates with extended healthspan in mice.: Mouse Asap3 KO study: ASAP3 deficiency improves hepatocyte mitochondrial function as part of a coordinated actin–autophagy–mitochondria rescue driving lifespan extension, offering in vivo mammalian support for cytoskeleton-linked mitochondrial quality control. [animal-model] (novelty: 3)
- 2026-07-17 — Manganese overload as a previously underappreciated trigger of cellular senescence: Unraveling mechanisms and therapeutic rescue by the senolytic quercetin.: 2026 C. elegans + PC12 study nominates manganese overload as an environmental trigger of mitochondrial dysfunction upstream of senescence, adding a heavy-metal input to the ROS/quality-control axis feeding SASP; quercetin partially rescued the mitochondrial phenotype. [animal-model] (novelty: 3)
- 2026-07-20 — Theca cells: active orchestrators of ovarian aging.: 2026 theca-cell review frames theca-cell mitochondrial failure as a proximal lesion coupling steroidogenic (P450scc/StAR) collapse to senescence and SASP, with mitochondria-targeted rescue reported in preclinical ovarian aging models — narrative synthesis, no new mitochondrial endpoints. [expert-opinion] (novelty: 3)
- 2026-08-01 — Ammonia Metabolism in the Aging Liver: Emerging Mechanistic Insights.: 2026 hepatic-ammonia review nominates accumulating ammonia in the aged liver as a proximal driver of mitochondrial injury (bioenergetic impairment, ROS, quality-control failure) in hepatocytes and downstream tissues — conceptual framing, no new mitochondrial endpoints. [mechanism-plausible] (novelty: 3)
- 2026-07-29 — Complosome as a key modulator of cellular senescence, aging and age-related diseases.: 2026 complosome review implicates intracellular C3/C5 in mitochondrial metabolism and quality-control regulation via AMPK/mTOR crosstalk, extending the mitochondrial-aging picture to an intracellular-complement input — mechanistic framing, no new mitochondrial endpoints. [mechanism-plausible] (novelty: 3)
- 2026-07-31 — The Physical Senotype in cellular senescence: Mechanical and physical strategies for senotherapy.: 2026 Physical Senotype review notes cytoskeletal/mechanical remodeling in senescent cells couples to altered mitochondrial positioning and dynamics, invoking the mechanical state as an indirect input to age-related mitochondrial dysfunction; framing only, no mitochondrial endpoints. [expert-opinion] (novelty: 3)
- 2026-08-05 — The Immunometabolic Bridge: Targeting Metainflammation to Prevent the Transition from Obesity to Cardiovascular Disease.: 2026 obesity-to-CVD review implicates adipocyte mitochondrial dysfunction as one upstream node of the metainflammation bridge feeding vascular pathology, framed within a tiered-prevention ladder rather than as an isolated bioenergetic lesion — conceptual synthesis, no new mitochondrial endpoints. [expert-opinion] (novelty: 3)
- 2026-08-12 — Mitochondrial stress activates ELT-2-dependent lysosomal proteostasis to extend lifespan in.: C. elegans study: mild mitochondrial respiratory stress extends lifespan via intestinal ELT-2-driven transcription of lysosomal proteases, enhancing proteostasis and polyQ clearance independently of UPRmt — adds a concrete transcriptional axis to the mitohormesis picture, worm-only. [animal-model] (novelty: 3)
- 2026-08-01 — Cardiometabolic Aging Driven by Multi-Organ Crosstalk: Mechanisms and Therapeutic Strategies.: 2026 cardiac-aging crosstalk review names cardiomyocyte oxidative stress and mitochondrial ROS as a shared convergence node for adipose-, muscle-, gut-, and kidney-derived signals driving the aging heart — mechanistic framing, no new mitochondrial endpoints. [expert-opinion] (novelty: 3)
- 2026-08-10 — Transcriptomics reveals species-specific adaptive strategies to calorie restriction in two Argopecten scallops with distinct lifespans.: Comparative CR transcriptomics in two Argopecten scallops reports species-specific remodeling of OXPHOS-related modules under CR, framed as part of a divergent bioenergetic adaptive strategy in the longer- vs shorter-lived species — descriptive transcriptomics, no functional mitochondrial endpoints. [animal-model] (novelty: 3)
- 2026-08-17 — Ovarian aging and systemic health: Mechanisms and emerging intervention strategies.: 2026 ovarian-aging review lists oocyte and granulosa-cell mitochondrial dysfunction (bioenergetic decline, mtDNA damage, quality-control failure) among the intrinsic cellular defects driving ovarian aging and, via endocrine and SASP spillover, systemic aging in females — narrative synthesis, no new mitochondrial endpoints. [expert-opinion] (novelty: 3)
- 2026-08-26 — Rapamycin attenuates age-related atrial remodeling and fibrillation by targeting HIF-1α-mediated metabolic dysregulation.: D-galactose aging mouse study frames HIF-1α–mediated atrial metabolic dysregulation (glycolytic shift and impaired oxidative metabolism) as the proximal bioenergetic lesion driving age-related atrial remodeling and AF, with rapamycin rescuing the metabolic phenotype. [animal-model] (novelty: 3)
- 2026-07-29 — A Purified Lycii Fructus Polysaccharide Fraction Extends Healthspan inwith an ATFS-1/UBL-5-Associated Mitochondrial Unfolded Protein Response.: 2026 Lycii Fructus polysaccharide (FSP) study: alongside C. elegans lifespan extension, FSP improved mitochondrial function readouts in human dermal fibroblasts, adding a plant-polysaccharide-to-mitochondria link via UPRmt activation — fibroblast-level evidence only, no in vivo mammalian mitochondrial endpoint. [mechanism-plausible] (novelty: 3)
- 2026-08-18 — Spatial niche remodeling of senescent liver-resident immune cells and its role in chronic liver diseases.: 2026 liver-resident immune-cell senescence review places mitochondrial dysfunction and mtDNA leakage upstream of cGAS–STING-driven SASP in Kupffer cells and hepatic lymphocytes, situating mitochondrial failure as a proximal trigger in the steatosis-to-HCC trajectory — conceptual framing only. [expert-opinion] (novelty: 3)
- 2026-08-20 — Luteolin promotes healthy aging in adult females but shortens lifespan after embryonic exposure in.: Model-organism study: adult luteolin improved healthspan and lifespan in females alongside antioxidant/redox effects invoked as part of the mechanism, indirectly implicating attenuation of mitochondrial oxidative stress; no direct mitochondrial-flux endpoints reported. [animal-model] (novelty: 3)
- 2026-09-06 — Mitochondria-endoplasmic reticulum contact sites (MERCS/MAM): Multi-layered upstream regulators of microglial senescence in Alzheimer’s disease.: 2026 MERCS/MAM–AD review frames mitochondrial fission–fusion imbalance and Ca²⁺ overload at ER contact sites as the proximal mitochondrial lesion feeding microglial senescence in AD, situating contact-site geometry as an upstream node of age-related mitochondrial dysfunction — narrative synthesis, no new mitochondrial endpoints. [mechanism-plausible] (novelty: 3)
- 2026-09-08 — LAPTM5 correlates with RPE senescence and subretinal fibrosis through the LAPTM5-WWP2-OPTN mitophagy cascade and cGAS/STING activation in a D-galactose-induced aging model.: 2026 D-gal RPE study frames impaired OPTN-mediated mitophagy — secondary to LAPTM5-driven WWP2 degradation — as the proximal mitochondrial quality-control lesion feeding cytosolic mtDNA release and cGAS–STING activation in RPE aging. [animal-model] (novelty: 3)
- 2026-07-01 — A critical role for mitochondrial dynamics in cigarette smoke condensate-induced RPE senescence.: 2026 RPE/mouse smoke-exposure study nominates a biphasic DRP1/PGAM5 mitochondrial fission defect with reduced mitochondrial turnover and elevated mtROS as the proximal mitochondrial lesion driving RPE aging under cigarette smoke, adding fission-machinery dysregulation (not just biogenesis/mitophagy) to the age-related mitochondrial decline picture. [animal-model] (novelty: 3)
- 2026-07-01 — Multi-omics profiling reveals systemic rejuvenation of the aged kidney through senolytic therapy.: 2026 aged-mouse kidney multi-omics: long-term D+Q reactivated PPARα and fatty-acid oxidation programs in tubular cells, coupling senolytic clearance to restored mitochondrial lipid metabolism as a proposed rejuvenation mechanism. [animal-model] (novelty: 3)
- 2026-04-02 — Ginsenoside Rg1 enhances stem cell abundance in aging human skeletal muscle after resistance exercise.: Small randomized crossover trial in women >60: 10 mg ginsenoside Rg1 pre-resistance-exercise roughly doubled high-mitochondrial mesenchymal stem cell abundance and total muscle mitochondrial content versus exercise alone, providing early human evidence that a TCM compound can amplify exercise-induced mitochondrial/stem-cell responses in aged muscle. [human-rct] (novelty: 3)
- 2026-07-03 — Delayed molecular aging, preservation of energy metabolism and enhanced exercise response in exercise-trained human muscle.: Human multiomic muscle atlas (transcriptome/lipidome/metabolome) in trained vs untrained older adults: sustained training preserves ~50% of youth-like skeletal-muscle energy-metabolism profiles and higher fitness amplifies acute exercise responses in mitochondrial, lipid, stress, and NAD-related pathways — cross-sectional/observational human data, not an RCT. [human-observational] (novelty: 3)
- 2026-07-01 — A Non-Canonical Role for Hepatocyte MLKL in Promoting Mitochondrial Dysfunction and Senescence in the Aging Liver.: 2025/2026 mouse hepatocyte MLKL overexpression study: non-necroptotic MLKL activity induces hepatocyte mitochondrial dysfunction upstream of senescence in the aging liver, extending MLKL biology beyond membrane-permeabilizing cell death into a mitochondrial quality-control lesion. [animal-model] (novelty: 3)
- 2026-06-24 — Mitochondrial transcription factor A: linking mtDNA maintenance, mitochondrial stress responses, and inflammaging.: 2026 TFAM review consolidates mitochondrial transcription factor A as a stoichiometric linchpin coupling mtDNA copy-number control and nucleoid packaging to mitochondrial stress responses and age-related mitochondrial dysfunction, and warns that simple TFAM overexpression may disrupt rather than restore homeostasis — synthesis, no new primary data. [expert-opinion] (novelty: 3)
- 2026-07-09 — Cell-Type-Specific Calibration of Mitochondrial Ubiquitination in Stem Cell Fate Decisions.: 2025 review reframes mitochondrial ubiquitination (Parkin and non-Parkin E3 ligases MARCH5/MUL1/RBX2) as a cell-type-calibrated quality-control layer whose miscalibration underlies stem-cell mitochondrial dysfunction in aging — synthesis, no new organismal data. [expert-opinion] (novelty: 3)
- 2026-07-13 — Sleep-related Alzheimer’s disease vulnerability in aging: A muscle-metabolic perspective.: 2026 sleep–AD vulnerability review implicates muscle insulin resistance and sarcopenic-obesity metabolic dysfunction (with mitochondrial bioenergetic decline in muscle) as upstream contributors to sleep destabilization and downstream brain amyloid/tau dyshomeostasis — conceptual placement of muscle mitochondrial aging in a sleep–brain axis, no primary mitochondrial endpoints. [mechanism-plausible] (novelty: 3)
- 2026-06-29 — Mechanistic redundancy and hierarchy of aging mechanisms: implications for strategies to extend healthspan and biomarker integration.: 2026 hierarchy review keeps mtDNA damage as a primary insult but positions bulk mitochondrial dysfunction as a downstream tier that reflects upstream drivers, arguing biomarker panels should distinguish primary mtDNA lesions from secondary bioenergetic decline — framing claim only. [expert-opinion] (novelty: 3)
- 2026-07-03 — Chlorella Hot Water Extract Restores Collagen Production in Senescent Fibroblasts Through Reversal of miR-193a-5p-Mediated Translational Repression of COL1A1.: 2026 in vitro study: chlorella hot water extract improves mitochondrial bioenergetics and redox balance in senescent human fibroblasts alongside restored COL1A1 translation, linking mitochondrial/redox rescue to reversal of a senescence-associated ECM deficit — fibroblast culture only, no in vivo endpoint. [mechanism-plausible] (novelty: 3)
- 2026-07-15 — The SIRT5-SUCLG2 desuccinylation axis delays ovarian aging via a mitochondrial-epigenetic regulatory mechanism.: 2026 mouse ovarian aging study: impaired SIRT5 desuccinylation of mitochondrial SUCLG2 perturbs TCA-cycle flux and floods acetyl-CoA into the nucleus to raise H4K8ac, operationalizing mito-nuclear crosstalk as a driver of tissue aging; desuccinylation-mimetic gene therapy rescues the phenotype in vivo. [animal-model] (novelty: 3)
- 2026-07-17 — Palmitoylation in cardiovascular aging and disease: Mechanistic insights and therapeutic opportunities.: 2026 palmitoylation-in-CV-aging review invokes altered S-palmitoylation of mitochondrial and metabolic proteins as an upstream post-translational contributor to age-related mitochondrial dysfunction in the cardiovascular system — mechanistic framing only, no new mitochondrial endpoints. [mechanism-plausible] (novelty: 3)
- 2026-07-19 — Rethinking frailty as a disorder of mitochondrial adaptability, from energetic congestion to systemic vulnerability.: 2026 perspective reframes age-related mitochondrial decline in frailty as ‘energetic congestion’ — chronic substrate oversupply relative to falling demand impairing mitochondrial adaptability — rather than primary bioenergetic insufficiency, predicting demand-side interventions (exercise) will outperform substrate supplementation (e.g., NAD+/urolithin/energy fuels); conceptual reframing, no primary data. [expert-opinion] (novelty: 3)
- 2026-07-01 — Gut Metabolism Links Precision Nutrition, Exercise, and Healthspan in Drosophila melanogaster.: 2026 Drosophila study: methionine restriction + taurine + moderate exercise additively extends lifespan, with enhanced gut mitochondrial TCA-cycle flux proposed as a partial mediator — fly-level mechanistic evidence, no mammalian mitochondrial endpoint. [animal-model] (novelty: 3)
- 2026-08-10 — Alterations of actin in aging.: 2026 actin-aging review argues age-related actin disorganization impairs mitochondrial dynamics, positioning, and quality control, framing the cytoskeleton as a mechanical upstream node of mitochondrial decline — conceptual linkage, no new mitochondrial endpoints. [mechanism-plausible] (novelty: 3)
- 2026-08-10 — Preserving joint healthspan in knee osteoarthritis: a geroscience-guided review of non-surgical therapies and genicular artery embolization.: 2026 KOA geroscience review invokes chondrocyte mitochondrial dysfunction as one hallmark contributing to cartilage aging, framed alongside senescence and inflammaging; exercise is highlighted as the intervention with plausible mitochondrial-quality-control effects, while injectables and genicular artery embolization are not tied to a mitochondrial endpoint — mechanistic framing only. [expert-opinion] (novelty: 3)
- 2026-08-11 — Pentadecanoic acid as a potential endogenous mTOR modulator for age-related female infertility: Mechanistic insights, molecular docking evidence, and therapeutic perspectives.: 2026 review frames pentadecanoic acid as supporting oocyte mitochondrial function via PPAR/AMPK-linked fatty-acid oxidation and reduced mTOR-driven anabolic load — mechanistic speculation tied to reproductive aging, no primary mitochondrial endpoint data. [mechanism-plausible] (novelty: 3)
- 2026-04-01 — Dilating the aging clock with light.: 2026 review positions optogenetic control of mitochondrial membrane potential and PDT-induced mitochondrial ROS as fast, organelle-specific ways to model mitochondrial aging phenotypes in days, offering causal dissection tools beyond chemical stressors — synthesis, no primary data. [expert-opinion] (novelty: 3)
- 2026-08-12 — PRMT6 drives hearing loss by promoting asymmetric arginine dimethylation-mediated FOXG1 degradation and suppressing mitophagy.: 2026 mouse + cochlear cell-line study nominates a PRMT6→FOXG1-degradation→mitophagy-suppression axis as an upstream driver of mitochondrial quality-control failure in D-gal-induced cochlear aging. [animal-model] (novelty: 3)
- 2026-08-01 — The GLP-1-Mitochondria Axis in Metabolic Aging.: 2026 narrative review proposes a GLP-1–mitochondria axis (biogenesis, dynamics, mitophagy) as a mechanism underlying metabolic-aging effects of GLP-1RAs; integrates SELECT outcomes with a 2025 mouse multi-omic study, but no human trial has used a prespecified mitochondrial endpoint. [mechanism-plausible] (novelty: 3)
- 2026-09-01 — hTERT Immortalization Stabilizes Human Umbilical Cord MSCs and Maintains Their Small Extracellular Vesicles With Preserved Immunomodulatory Activity and Primordial Follicle-Activating Capacity.: 2026 preclinical study: hTERT immortalization of late-passage human umbilical cord MSCs attenuates passage-associated mitochondrial dysfunction alongside senescence, consistent with telomerase having non-canonical mitochondrial-protective effects in aged stromal cells. [mechanism-plausible] (novelty: 3)
- 2026-08-26 — The Reductive Stress Nexus: Integrated Pathways of Metabolic Dysregulation, Senescence and Blood-Brain Barrier Failure in Neurodegenerative Disease and Brain Aging.: 2026 review argues reductive stress (excess NAD(P)H/GSH) impairs electron-transport flux and drives paradoxical ROS generation, coupling mitochondrial dysfunction to senescence and neuroinflammation in brain aging; mechanistic framing only. [mechanism-plausible] (novelty: 3)
- 2026-08-17 — Epigenetic Skeletal Muscle Memory: The Impact of Physical Activity on Aging and Post-Injury Regeneration.: Review invokes mitochondrial epigenetic adaptations (mtDNA methylation, biogenesis priming) as a component of exercise-induced muscle memory that degrades with age-related mitochondrial decline; conceptual synthesis, not new data. [mechanism-plausible] (novelty: 3)
- 2026-09-02 — Mitochondrial Microautophagy: An Emerging Pathway in Maintaining Mitochondrial Homeostasis.: Mechanistic review proposes mitochondrial microautophagy as a ROS-guided quality-control pathway that excises damaged sub-organelle domains without whole-organelle turnover, distinct from classical mitophagy; framed as relevant to age-related mitochondrial decline but no direct lifespan/healthspan data. [mechanism-plausible] (novelty: 3)
Open questions
Related
Contributing findings
#416 ‒ The science of mitochondria: their role in health, aging, and disease, and what the evidence says about drugs and supplements aimed at improving their function | Navdeep Chandel, Ph.D.
16-nov-2026
novelty 2
per-area 2
strengthens
Identification of mitophagy inducers for Alzheimer's disease via high-throughput endogenous ATP5B tagging system.
14-nov-2026
novelty 3
per-area 3
strengthens
Metabolic syndrome and Alzheimer's disease: Mechanistic links and precision prevention (Review).
13-nov-2026
novelty 2
per-area 2
strengthens
The mitophagy-ferroptosis nexus in cardiac aging: A proposed exercise-responsive framework.
13-nov-2026
novelty 3
per-area 3
strengthens
Cellular senescence and the hallmarks of ageing: Evaluating evidence for a causal mechanistic role.
13-nov-2026
novelty 3
per-area 3
strengthens
Neuropeptide signaling regulates mitochondrial UPR activity and extended lifespan resulting from methionine restriction.
13-nov-2026
novelty 3
per-area 3
strengthens
Vascular Senescence and Atherosclerotic Plaque Vulnerability
12-nov-2026
novelty 2
per-area 2
mentions
The Short Peptide Elamipretide Delays Ovarian Aging in Mice
11-nov-2026
novelty 3
per-area 3
strengthens
Engineering ATP import in yeast uncovers a synthetic route to extend cellular lifespan.
11-nov-2026
novelty 4
per-area 4
strengthens
Urolithin A plus EGCG enhances mitophagy associated pathways, mitochondrial dynamics, and bioenergetic function in humanized amyloid-β knock-in mice.
10-nov-2026
novelty 3
per-area 3
strengthens
When genomes burn: how DNA damage ignites inflammation and fuels ageing.
01-nov-2026
novelty 2
per-area 2
mentions
Whey protein hydrolysate rich in branched-chain amino acid-containing oligopeptide as a novel nutritional strategy to attenuate age-related muscle weakness.
30-oct-2026
novelty 3
per-area 2
strengthens
Biological functions and emerging interplay of FGF21 and GDF15 in metabolic diseases and aging.
30-oct-2026
novelty 2
per-area 2
strengthens
Metabolic exhaustion underlies sarcopenic obesity susceptibility in aging mice as revealed by multi-omics factor analysis.
29-oct-2026
novelty 3
per-area 3
strengthens
A stress-adapted fiber state promotes clonal expansion of deleted mitochondrial DNA.
29-oct-2026
novelty 3
per-area 3
strengthens
Proteostasis stress alters mitochondrial levels and localization of SOD2 during cellular senescence.
20-oct-2026
novelty 3
per-area 3
strengthens
From Benefit to Harm: Context-Dependent Responses to Dietary Interventions.
20-oct-2026
novelty 3
per-area 3
strengthens
Mitochondria-targeted drug delivery systems for aging-related diseases: Mechanisms, strategies, and advances.
16-oct-2026
novelty 2
per-area 2
strengthens
Proteomic and β-hydroxybutyrylation Landscapes Reveal AMPKα2-Associated Modulation in HUCMSC-Derived Exosome-Mediated Amelioration of Cardiac Aging.
15-oct-2026
novelty 3
per-area 3
strengthens
The mechanism of dietary intervention in delaying brain aging and neurodegenerative diseases.
13-oct-2026
novelty 2
per-area 2
strengthens
Antioxidant Therapy, N-acetyl-L-cysteine, Effects on Pancreatic Beta Cells: Therapeutic Promise or Potential Harm?
10-oct-2026
novelty 3
per-area 2
mentions
Adropin signaling pathways in metabolic and non-metabolic disorders.
10-oct-2026
novelty 2
per-area 2
strengthens
Sulfur amino acid restriction and caloric restriction induce divergent redox metabolism-related adaptations in male F344 rats.
10-oct-2026
novelty 3
per-area 2
mentions
THE AGING PURINOME: A PURINERGIC FRAMEWORK LINKING THE HALLMARKS OF AGING TO INFLAMMAGING.
10-oct-2026
novelty 3
per-area 3
strengthens
Effects of kinetin on thymic lymphocyte proliferation, mitochondrial membrane potential, and apoptosis-regulatory gene expression in D-galactose-induced aging rats.
08-oct-2026
novelty 2
per-area 2
strengthens
Phosphodiesterase 4 inhibitors extend lifespan of C. elegans and attenuate cellular senescence of mouse embryonic fibroblasts.
08-oct-2026
novelty 3
per-area 3
strengthens
Lysine degradation-related metabolic remodeling in sarcopenia: Mendelian randomization prioritization and multi-omics-based characterization.
07-oct-2026
novelty 3
per-area 3
strengthens
Weight Loss or Muscle Loss? Cellular Mechanisms and Clinical Strategies for Preserving Lean Mass During GLP-1-Based Therapy.
07-oct-2026
novelty 3
per-area 2
mentions
Reduced Cardiolipin Levels as a Cause of Mitochondrial Dysfunction and Muscle Remodeling
06-oct-2026
novelty 2
per-area 2
strengthens
Multimodal Technology-Driven aging Research: Decoding the Mitochondria‒Pyroptosis axis in muscle atrophy and cognitive decline.
06-oct-2026
novelty 3
per-area 3
strengthens
Differences of oxidative damage in the brain of short- and long-lived Nothobranchius furzeri strains.
06-oct-2026
novelty 2
per-area 2
strengthens
The Impact of Biological Mechanisms of Aging on Response Variability to Resistance Training in Older Adults
05-oct-2026
novelty 2
per-area 2
mentions
K21 Improves Mitochondrial Function in Macrophages, Extending Life in Nematode Worms
05-oct-2026
novelty 3
per-area 3
strengthens
Beyond Inflammation: The NLRP3 Inflammasome as a Cellular and Mechanical Hub of Vascular Remodeling in Hypertension.
05-oct-2026
novelty 2
per-area 2
mentions
Electroacupuncture Targeting the NLRP3 Inflammasome in Senescence‑associated Cognitive Impairment: Mechanistic Synthesis and Meta‑analysis of Clinical Randomized Controlled Trials.
05-oct-2026
novelty 3
per-area 2
strengthens
Caloric restriction mimetics rewire the AMPK-mTOR-ULK1 signaling nexus to restore autophagic proteostasis in the aging brain.
05-oct-2026
novelty 2
per-area 2
mentions
Elamipretide Rejuvenates Oocyte Quality and Restores Female Fertility During Reproductive Aging
03-oct-2026
novelty 3
per-area 3
strengthens
Prodh2‐Mediated Mitochondrial Stress Drives TNF‐α‐Induced Myoblast Dysfunction and Sarcopenia in COPD
02-oct-2026
novelty 2
per-area 2
strengthens
Correction to “A Non‐Canonical Role for Hepatocyte MLKL in Promoting Mitochondrial Dysfunction and Senescence in the Aging Liver”
02-oct-2026
novelty 1
per-area 1
mentions
Are we at risk of increasing sarcopenia? Implications for osteoarthritis and osteoporosis.
02-oct-2026
novelty 2
per-area 2
mentions
Proteomic and bioinformatic profiling of the aging mouse heart-diaphragm system.
02-oct-2026
novelty 2
per-area 2
strengthens
Mitochondrial Transplantation Rejuvenates Aging Heart by Restoring Mitophagy Flux via the HIF-3α-BNIP3 Axis.
01-oct-2026
novelty 3
per-area 3
strengthens
Correction to "A Non-Canonical Role for Hepatocyte MLKL in Promoting Mitochondrial Dysfunction and Senescence in the Aging Liver".
01-oct-2026
novelty 1
per-area 1
mentions
Hepatocyte Growth Hormone Receptor Ablation Is Associated With Aging Phenotypes and Hepatic Mitochondrial Dysfunction.
01-oct-2026
novelty 3
per-area 3
strengthens
Ferroptosis-Driven Inflammaging in Age-Associated Degenerative Disorders: Molecular Mechanisms and Therapeutic Potential of Natural Products.
01-oct-2026
novelty 2
per-area 1
mentions
Mitochondrial Respiration in Peripheral Blood Cells Links to Metabolic Flexibility and Physical Performance in Ageing.
01-oct-2026
novelty 3
per-area 2
strengthens
Traditional Chinese Medicine Formulas in Delaying Aging: From Theoretical Foundations to Molecular Mechanisms and Translational Perspectives.
01-oct-2026
novelty 3
per-area 3
strengthens
Traditional Chinese medicine-derived natural products and formulations as pharmacological modulators of ageing-related pathways: mechanisms and therapeutic potential.
01-oct-2026
novelty 2
per-area 2
mentions
Mitochondria and associated complexes as therapeutic targets in aging: From biomacromolecular structure-function insights to clinical translation.
01-oct-2026
novelty 2
per-area 3
strengthens